• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据维甲酸和牛血清白蛋白添加方法建立最佳药物递送系统及水凝胶隐形眼镜利用情况评估

Establishment of Optimal Drug Delivery System and Evaluation of Utilization of Hydrogel Contact Lens According to the Addition Method of Tretinoin and Bovine Serum Albumin.

作者信息

Park Hye-In, Sung A-Young

机构信息

Department of Optometry & Vision Science, Daegu Catholic University, Gyeongsan 38430, Republic of Korea.

出版信息

Polymers (Basel). 2025 Jan 10;17(2):159. doi: 10.3390/polym17020159.

DOI:10.3390/polym17020159
PMID:39861232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11768321/
Abstract

This study aims to build an optimal drug delivery system by manufacturing and evaluating a hydrogel contact lens using Tretinoin (ATRA) and protein nanoparticles to improve the drug delivery system as an ophthalmic medical contact lens. To evaluate the optical and physical properties of the manufactured lens, the spectral transmittance, refractive index, water content, contact angle, AFM, tensile strength, drug delivery, and antibacterial properties were analyzed. The contact lens was manufactured to contain ATRA and bovine serum albumin (BSA) in different ways, and the results confirmed that A, B, and C each had different physical properties. In particular, for Sample A, using the soak and release method and using ATRA solution in the contact lens with BSA added, the wettability was 55.94°, the tensile strength was 0.1491 kgf/mm, and drug delivery released 130.35 μm over 336 h, which was found to be superior to samples B and C. Therefore, the three hydrogel contact lenses compared in this study according to the addition method of ATRA and BSA can be used in various ways to build an optimal drug delivery system that is very useful as an ophthalmic medical lens.

摘要

本研究旨在通过制备和评估一种使用维甲酸(全反式维甲酸,ATRA)和蛋白质纳米颗粒的水凝胶隐形眼镜来构建一种优化的药物递送系统,以改进作为眼科医用隐形眼镜的药物递送系统。为了评估所制备镜片的光学和物理性质,对光谱透过率、折射率、含水量、接触角、原子力显微镜、拉伸强度、药物递送和抗菌性能进行了分析。以不同方式制备了含有ATRA和牛血清白蛋白(BSA)的隐形眼镜,结果证实A、B和C各自具有不同的物理性质。特别是对于样品A,采用浸泡和释放方法,并在添加了BSA的隐形眼镜中使用ATRA溶液,其润湿性为55.94°,拉伸强度为0.1491 kgf/mm,在336小时内药物递送释放量为130.35μm,发现优于样品B和C。因此,本研究中根据ATRA和BSA添加方法比较的三种水凝胶隐形眼镜可以以各种方式用于构建一种优化的药物递送系统,该系统作为眼科医用镜片非常有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/11768321/2ccfd1f56625/polymers-17-00159-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/11768321/191f6c1983a9/polymers-17-00159-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/11768321/134e800af662/polymers-17-00159-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/11768321/595b91f811ba/polymers-17-00159-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/11768321/1cafbcc5058b/polymers-17-00159-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/11768321/cb8fa17ca780/polymers-17-00159-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/11768321/46c67e654cfc/polymers-17-00159-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/11768321/8fe5da8d5eea/polymers-17-00159-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/11768321/e1620fdb01c6/polymers-17-00159-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/11768321/2ccfd1f56625/polymers-17-00159-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/11768321/191f6c1983a9/polymers-17-00159-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/11768321/134e800af662/polymers-17-00159-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/11768321/595b91f811ba/polymers-17-00159-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/11768321/1cafbcc5058b/polymers-17-00159-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/11768321/cb8fa17ca780/polymers-17-00159-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/11768321/46c67e654cfc/polymers-17-00159-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/11768321/8fe5da8d5eea/polymers-17-00159-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/11768321/e1620fdb01c6/polymers-17-00159-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/11768321/2ccfd1f56625/polymers-17-00159-g009.jpg

相似文献

1
Establishment of Optimal Drug Delivery System and Evaluation of Utilization of Hydrogel Contact Lens According to the Addition Method of Tretinoin and Bovine Serum Albumin.根据维甲酸和牛血清白蛋白添加方法建立最佳药物递送系统及水凝胶隐形眼镜利用情况评估
Polymers (Basel). 2025 Jan 10;17(2):159. doi: 10.3390/polym17020159.
2
Effect of Graphene Nanoparticles on the Physical Properties of Ophthalmic Polymer Containing Pyrrolidone Group.含吡咯烷酮基团的眼科用聚合物中石墨烯纳米粒子对物理性能的影响。
J Nanosci Nanotechnol. 2019 Oct 1;19(10):6516-6523. doi: 10.1166/jnn.2019.17074.
3
Poly (Ethylene Glycol) Methyl Ether Methacrylate-Based Hydrogel and Cerium(IV) Oxide Nanoparticles as Ophthalmic Lens Material.基于聚(乙二醇)甲基醚甲基丙烯酸酯的水凝胶和二氧化铈纳米颗粒作为眼科镜片材料
Micromachines (Basel). 2021 Sep 16;12(9):1111. doi: 10.3390/mi12091111.
4
Poly(2-hydroxyethyl methacrylate)/β-cyclodextrin-hyaluronan contact lens with tear protein adsorption resistance and sustained drug delivery for ophthalmic diseases.具有抗泪液蛋白吸附和眼科疾病持续药物递送功能的聚(甲基丙烯酸2-羟乙酯)/β-环糊精-透明质酸隐形眼镜
Acta Biomater. 2020 Jul 1;110:105-118. doi: 10.1016/j.actbio.2020.04.002. Epub 2020 Apr 24.
5
Controlled release of naringenin from soft hydrogel contact lens: An investigation into lens critical properties and in vitro release.从软性水凝胶隐形眼镜中控制柚皮苷的释放:对隐形眼镜关键性能和体外释放的研究。
Int J Pharm. 2022 Jun 10;621:121793. doi: 10.1016/j.ijpharm.2022.121793. Epub 2022 May 6.
6
Study on the Wettability of Ophthalmic Hydrogel Lens Containing Graphene Oxide Nanoparticles with Wettability Measurement Method.采用润湿性测量方法对含氧化石墨烯纳米颗粒的眼科水凝胶镜片润湿性的研究
J Nanosci Nanotechnol. 2018 Oct 1;18(10):6978-6982. doi: 10.1166/jnn.2018.15487.
7
Phenylboronic acid modified hydrogel materials and their potential for use in contact lens based drug delivery.苯硼酸改性水凝胶材料及其在隐形眼镜给药中的应用潜力。
J Biomater Sci Polym Ed. 2022 Oct;33(15):1924-1938. doi: 10.1080/09205063.2022.2088531. Epub 2022 Jun 20.
8
Albumin/Hyaluronic Acid Nanoparticle-Laden Contact Lenses for the Ocular Delivery of 5-Fluorouracil.载白蛋白/透明质酸纳米粒子隐形眼镜经眼部递送 5-氟尿嘧啶。
J Biomed Mater Res A. 2025 Jan;113(1):e37839. doi: 10.1002/jbm.a.37839.
9
Preparation and Characterization of High Functional Ophthalmic Lens Material Containing Acrylic Formation Isocyanate Group with Carbon Nanoparticles.含碳纳米粒子的含丙烯酰基异氰酸酯基团的高功能性眼科透镜材料的制备与表征。
J Nanosci Nanotechnol. 2019 Oct 1;19(10):6225-6231. doi: 10.1166/jnn.2019.17036.
10
Preparation and Analysis of Functional Silicone Hydrogel Lenses Containing ZrO₂ and Antimony Tin Oxide Nanoparticles.ZrO₂ 和掺锑氧化锡纳米颗粒功能硅水凝胶隐形眼镜的制备与分析。
J Nanosci Nanotechnol. 2021 Sep 1;21(9):4649-4653. doi: 10.1166/jnn.2021.19291.

引用本文的文献

1
Applications of Hydrogels in Emergency Therapy.水凝胶在急救治疗中的应用。
Gels. 2025 Mar 23;11(4):234. doi: 10.3390/gels11040234.

本文引用的文献

1
Recent Progress of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Ocular Drug Delivery Platforms.固体脂质纳米粒和纳米结构脂质载体作为眼部药物递送平台的研究进展
Pharmaceuticals (Basel). 2023 Mar 22;16(3):474. doi: 10.3390/ph16030474.
2
Protein-Based Nanoparticles as Drug Delivery Systems.基于蛋白质的纳米颗粒作为药物递送系统
Pharmaceutics. 2020 Jun 29;12(7):604. doi: 10.3390/pharmaceutics12070604.
3
Photostability of Topical Agents Applied to the Skin: A Review.应用于皮肤的外用制剂的光稳定性:综述
Pharmaceutics. 2019 Dec 20;12(1):10. doi: 10.3390/pharmaceutics12010010.
4
Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy.纳米技术制剂药物的临床前免疫毒性研究:挑战、考量与策略
J Control Release. 2015 Dec 28;220(Pt B):571-83. doi: 10.1016/j.jconrel.2015.08.056. Epub 2015 Sep 5.
5
Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines.构象稳定的流感 M2e 自组装纳米簇作为广泛交叉保护的流感疫苗。
Nanomedicine. 2014 Feb;10(2):473-82. doi: 10.1016/j.nano.2013.08.005. Epub 2013 Aug 27.
6
Drug delivery systems for the eye.眼部给药系统
Expert Rev Med Devices. 2009 May;6(3):277-90. doi: 10.1586/erd.09.4.
7
Hydrogels for pharmaceutical and biomedical applications.用于制药和生物医学应用的水凝胶。
Crit Rev Ther Drug Carrier Syst. 2005;22(2):107-49. doi: 10.1615/critrevtherdrugcarriersyst.v22.i2.10.
8
Topical retinoid treatment for various dry-eye disorders.用于各种干眼症的局部维甲酸治疗。
Ophthalmology. 1985 Jun;92(6):717-27. doi: 10.1016/s0161-6420(85)33968-4.
9
Topical tretinoin treatment for severe dry-eye disorders.外用维甲酸治疗重度干眼疾病。
J Am Acad Dermatol. 1986 Oct;15(4 Pt 2):860-6. doi: 10.1016/s0190-9622(86)70243-0.